Quantcast
Home > Quotes > SRDX
SRDX

Surmodics, Inc. Common Stock (SRDX) Quote & Summary Data

$58.21
*  
0.20
0.34%
Get SRDX Alerts
*Delayed - data as of Nov. 15, 2018 12:56 ET  -  Find a broker to begin trading SRDX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    SRDX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 58.18 / $ 58.48
1 Year Target
66
Today's High / Low
$ 58.81 / $ 56.39
Share Volume
39,128
50 Day Avg. Daily Volume
98,221
Previous Close
$ 58.01
52 Week High / Low
$ 82.35 / $ 25
Market Cap
777,196,170
P/E Ratio
NE
Forward P/E (1y)
725.13
Earnings Per Share (EPS)
$ -0.34
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.38

Intraday Chart

Shares Traded

Share Volume:
39,128
50 Day Avg. Daily Volume:
98,221

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
725.13
Earnings Per Share (EPS):
$ -0.34

Trading Range

The current last sale of $58.21 is 132.84% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 58.81 $ 82.35
 Low: $ 56.39 $ 25

Company Description (as filed with the SEC)

Surmodics, Inc. and subsidiaries (referred to as "Surmodics," the "Company," "we," "us," "our" and other like terms) is a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry. Our mission is to improve the treatment and detection of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges. Our business segments partner with many of the world's leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. In fiscal 2017, our business performance continued to be driven by growth in our core Medical Device and In Vitro Diagnostics ("IVD") businesses, while we continued medical device product and platform development leveraging the technologies and manufacturing capabilities acquired with the fiscal 2016 acquisitions of Creagh Medical Ltd.  ... More ...  


Risk Grade

Where does SRDX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 57.59
Open Date:
Nov. 15, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x